TF and neoplasm: The global view of tumor glyco-code profiles upon separation of patients based on better or worse overall survival (median OS) (Figure 3A) or progression-free survival (median PFS) (Supplementary Figure S5A) revealed a pattern of higher expression of Thomsen-Friedenreich antigen (TF-antigen), GlcNAc, Fuc and NeuAc residues (seen by the fixation of ACA, WGA, RPL-αMan, UEA-I, MAA and SNA) in tumor cell lines from patients with worse clinical outcome.